Jiangsu Lianhuan Pharmaceutical Co., Ltd. (SHA:600513)
China
· Delayed Price · Currency is CNY 22.94
+1.05 (4.80%)
Apr 30, 2026, 1:55 PM CST
SHA:600513 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 6,249 | 5,227 | 2,829 | 3,180 | 2,696 | 2,782 | Upgrade
|
| Market Cap Growth | 108.28% | 84.76% | -11.04% | 17.94% | -3.08% | -6.30% | Upgrade
|
| Enterprise Value | 7,861 | 6,835 | 3,616 | 3,816 | 3,234 | 3,159 | Upgrade
|
| Last Close Price | 21.89 | 18.31 | 9.81 | 10.85 | 9.01 | 9.15 | Upgrade
|
| PE Ratio | - | - | 33.61 | 23.55 | 19.07 | 23.41 | Upgrade
|
| PS Ratio | 2.30 | 1.93 | 1.31 | 1.46 | 1.38 | 1.69 | Upgrade
|
| PB Ratio | 3.72 | 3.11 | 1.79 | 2.10 | 1.91 | 2.17 | Upgrade
|
| P/TBV Ratio | 6.39 | 5.34 | 2.22 | 2.58 | 2.33 | 2.62 | Upgrade
|
| P/OCF Ratio | - | - | 262.77 | 19.79 | 21.13 | 20.11 | Upgrade
|
| EV/Sales Ratio | 2.90 | 2.52 | 1.67 | 1.76 | 1.65 | 1.92 | Upgrade
|
| EV/EBITDA Ratio | 53.10 | 46.68 | 19.61 | 16.19 | 13.27 | 15.83 | Upgrade
|
| EV/EBIT Ratio | 159.12 | 138.36 | 28.97 | 21.21 | 15.94 | 18.42 | Upgrade
|
| Debt / Equity Ratio | 0.93 | 0.93 | 0.56 | 0.47 | 0.49 | 0.44 | Upgrade
|
| Debt / EBITDA Ratio | 10.49 | 10.49 | 4.77 | 2.99 | 2.83 | 2.80 | Upgrade
|
| Net Debt / Equity Ratio | 0.72 | 0.72 | 0.42 | 0.28 | 0.25 | 0.18 | Upgrade
|
| Net Debt / EBITDA Ratio | 8.22 | 8.22 | 3.56 | 1.80 | 1.47 | 1.14 | Upgrade
|
| Net Debt / FCF Ratio | -4.21 | -4.21 | -3.77 | -10.62 | -3.86 | -6.75 | Upgrade
|
| Asset Turnover | 0.76 | 0.76 | 0.74 | 0.78 | 0.77 | 0.75 | Upgrade
|
| Inventory Turnover | 3.22 | 3.22 | 2.91 | 3.80 | 3.79 | 3.77 | Upgrade
|
| Quick Ratio | 0.55 | 0.55 | 0.67 | 0.72 | 0.74 | 0.85 | Upgrade
|
| Current Ratio | 0.98 | 0.98 | 1.10 | 1.09 | 1.10 | 1.18 | Upgrade
|
| Return on Equity (ROE) | -5.17% | -5.17% | 6.88% | 10.33% | 12.35% | 11.36% | Upgrade
|
| Return on Assets (ROA) | 0.87% | 0.87% | 2.66% | 4.04% | 5.00% | 4.87% | Upgrade
|
| Return on Invested Capital (ROIC) | 1.70% | 1.93% | 4.88% | 8.38% | 10.88% | 10.62% | Upgrade
|
| Return on Capital Employed (ROCE) | 2.40% | 2.40% | 7.40% | 11.20% | 13.80% | 12.80% | Upgrade
|
| Earnings Yield | -1.57% | -1.88% | 2.97% | 4.25% | 5.24% | 4.27% | Upgrade
|
| FCF Yield | -4.57% | -5.47% | -6.15% | -1.26% | -3.45% | -1.21% | Upgrade
|
| Dividend Yield | 0.43% | - | 0.91% | 1.38% | 1.66% | 1.37% | Upgrade
|
| Payout Ratio | - | - | 60.08% | 37.94% | 38.48% | 33.48% | Upgrade
|
| Buyback Yield / Dilution | 0.34% | 0.34% | -1.03% | 0.44% | 0.46% | -1.31% | Upgrade
|
| Total Shareholder Return | 0.77% | 0.34% | -0.12% | 1.82% | 2.13% | 0.06% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.